Do we learn the right things from clinical trials?

被引：3
|
作者：
Garattini, Silvio [1 ]
Bertele, Vittorio [1 ]
机构：
[1] Mario Negri Inst Pharmacol Res, I-20156 Milan, Italy
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2008年 / 64卷 / 02期
关键词：
added value; adverse reactions; clinical end-points; clinical drug trials; comparators; design; conflicts of interest; randomization;
D O I：
10.1007/s00228-007-0411-4
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：115 / 125
页数：11
相关论文
共 50 条
  • [41] Systematic identification of pharmacogenomics information from clinical trials
    Li, Jiao
    Lu, Zhiyong
    JOURNAL OF BIOMEDICAL INFORMATICS, 2012, 45 (05) : 870 - 878
  • [42] Optimism bias' in contemporary national clinical trial network phase III trials: are we improving?
    Zakeri, K.
    Noticewala, S. S.
    Vitzthum, L. K.
    Sojourner, E.
    Shen, H.
    Mell, L. K.
    ANNALS OF ONCOLOGY, 2018, 29 (10) : 2135 - 2139
  • [43] Clinical pearls from glaucoma clinical trials: a case-based approach
    Barna, Laura E.
    Chung, In Young
    Shen, Lucy Q.
    CURRENT OPINION IN OPHTHALMOLOGY, 2025, 36 (02) : 99 - 106
  • [44] Why is so much clinical research ignored and what can we do about it?
    Grant, Aileen
    Treweek, Shaun
    Wells, Mary
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2016, 77 (10) : 554 - 555
  • [45] Analysing the demand side of e-government: What can we learn from slovenian users?
    Kunstelj, Mateja
    Jukic, Tina
    Vintar, Mirko
    ELECTRONIC GOVERNMENT, PROCEEDINGS, 2007, 4656 : 305 - +
  • [46] Communicating social research findings more effectively: what can we learn from other fields?
    Davies, Huw T. O.
    Powell, Alison E.
    EVIDENCE & POLICY, 2012, 8 (02): : 213 - 233
  • [47] Photocatalytic CO2 conversion: What can we learn from conventional COx hydrogenation?
    Kong, Tingting
    Jiang, Yawen
    Xiong, Yujie
    CHEMICAL SOCIETY REVIEWS, 2020, 49 (18) : 6579 - 6591
  • [48] Collaborative Design of Technology-Enhanced Learning: What can We Learn from Teacher Talk?
    McKenney S.
    Boschman F.
    Pieters J.
    Voogt J.
    TechTrends, 2016, 60 (4) : 385 - 391
  • [49] From the other side: The patient perspective on cancer clinical trials
    Bangs, Rick
    Crispino, Tony
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (05) : 331 - 335
  • [50] From Standardization to Adaptation: Clinical Trials and the Moral Economy of Anticipation
    Montgomery, Catherine M.
    SCIENCE AS CULTURE, 2017, 26 (02) : 232 - 254
12345